Clinical Trial Update: A Phase 2a Study To Evaluate The Pharmacokinetics, Safety, Efficacy, Tolerability, And Pharmacodynamics of Sotatercept (ACE-011) for the Correction of Anemia in Subjects With End-stage Renal Disease on Hemodialysis. [Phase 2]

View source ↗

Summary

A phase 2a study evaluated pharmacokinetics, safety, efficacy, tolerability, and pharmacodynamics of sotatercept (ACE-011) for correcting anemia in adults with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Drugs mentioned

• Sotatercept (sotatercept)

Snippet

Sponsor: Celgene | Conditions: Anemia | Phase 2 | Status: COMPLETED | Results posted: 2024-03-01